Matthew Malone, DO, MBA

Commentary

Recent Advances in Screening for Mild Cognitive Impairment and Alzheimer Disease

December 26, 2022

Among the most transformative Alzheimer disease discoveries is the existence of biomarkers which can manifest decades before onset of disease-related dementia.

Commentary

The Differential Diagnosis and Treatment of Mild Cognitive Impairment and Alzheimer Disease

December 26, 2022

Navigating the associated differential diagnosis in AD is essential as various causes of cognitive impairment require different treatment strategies.